- Home
- CNTB vs LGCL Comparison
CNTB vs LGCL Comparison
Compare CNTB & LGCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- LGCL
- Stock Information
- Founded
- CNTB 2012
- LGCL 2009
- Country
- CNTB United States
- LGCL China
- Employees
- CNTB N/A
- LGCL N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- LGCL
- Sector
- CNTB Health Care
- LGCL
- Exchange
- CNTB Nasdaq
- LGCL NYSE
- Market Cap
- CNTB 43.2M
- LGCL 39.7M
- IPO Year
- CNTB 2021
- LGCL 2024
- Fundamental
- Price
- CNTB $0.79
- LGCL $0.63
- Analyst Decision
- CNTB Strong Buy
- LGCL
- Analyst Count
- CNTB 1
- LGCL 0
- Target Price
- CNTB $8.00
- LGCL N/A
- AVG Volume (30 Days)
- CNTB 68.9K
- LGCL 92.2K
- Earning Date
- CNTB 05-15-2025
- LGCL 01-01-0001
- Dividend Yield
- CNTB N/A
- LGCL N/A
- EPS Growth
- CNTB N/A
- LGCL N/A
- EPS
- CNTB N/A
- LGCL 0.07
- Revenue
- CNTB $26,033,000.00
- LGCL $145,690,427.00
- Revenue This Year
- CNTB N/A
- LGCL N/A
- Revenue Next Year
- CNTB N/A
- LGCL N/A
- P/E Ratio
- CNTB N/A
- LGCL $9.15
- Revenue Growth
- CNTB N/A
- LGCL N/A
- 52 Week Low
- CNTB $0.51
- LGCL $0.28
- 52 Week High
- CNTB $2.07
- LGCL $3.31
- Technical
- Relative Strength Index (RSI)
- CNTB 50.92
- LGCL N/A
- Support Level
- CNTB $0.73
- LGCL N/A
- Resistance Level
- CNTB $0.85
- LGCL N/A
- Average True Range (ATR)
- CNTB 0.06
- LGCL 0.00
- MACD
- CNTB -0.00
- LGCL 0.00
- Stochastic Oscillator
- CNTB 51.07
- LGCL 0.00
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About LGCL LUCAS GC LIMITED
Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China. Its business segments consist of recruitment services, outsourcing services, and other services, which include information technology services and training services.